Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
INVESTING
5 Stock Gainers Tuesday: Rigel, Vaxart, Boeing, Nvidia and Moderna
By Rob Lenihan
Jul 14, 2020 11:22 PM EDT
PRESS RELEASES
Rigel To Present At The 39th Annual J.P. Morgan Healthcare Conference
By PR Newswire
Jan 7, 2021 7:30 AM EST
PRESS RELEASES
Rigel Announces Two Posters Highlighting TAVALISSE At The 62nd ASH Annual Meeting & Exposition
By PR Newswire
Dec 4, 2020 7:30 AM EST
PRESS RELEASES
Rigel Finalizes The Study Design Of Its Ongoing Phase 3 Clinical Trial Of Fostamatinib In Warm Autoimmune Hemolytic Anemia
By PR Newswire
Nov 17, 2020 7:30 AM EST
PRESS RELEASES
Rigel To Present At The Jefferies Virtual London Healthcare Conference
By PR Newswire
Nov 10, 2020 7:30 AM EST
PRESS RELEASES
Rigel Announces Conference Call And Webcast To Report Third Quarter 2020 Financial Results And Business Update
By PR Newswire
Oct 29, 2020 7:30 AM EDT
PRESS RELEASES
Rigel Announces NIH/NHLBI-Sponsored Trial Of Fostamatinib In Hospitalized COVID-19 Patients In Collaboration With Inova
By PR Newswire
Sep 17, 2020 7:30 AM EDT
PRESS RELEASES
Rigel To Present At Two Upcoming Investor Conferences
By PR Newswire
Sep 9, 2020 7:30 AM EDT
PRESS RELEASES
Rigel Pharmaceuticals, Inc. Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
By PR Newswire
Aug 21, 2020 7:30 AM EDT
PRESS RELEASES
Rigel Announces Conference Call And Webcast To Report Second Quarter 2020 Financial Results And Business Update
By PR Newswire
Jul 28, 2020 7:30 AM EDT
PRESS RELEASES
Rigel Announces Post-hoc Data Analysis Of TAVALISSE® In Adult Patients With Immune Thrombocytopenia Published In The British Journal Of Haematology
By PR Newswire
Jul 27, 2020 7:30 AM EDT
INVESTING
5 Stock Gainers Tuesday: Rigel, Vaxart, Boeing, Nvidia and Moderna
By Rob Lenihan
Jul 14, 2020 11:22 PM EDT
INVESTING
Rigel Pharma to Test Potential Drug for Covid-19 Pneumonia
By Tony Owusu
Jul 14, 2020 1:15 PM EDT
PRESS RELEASES
Rigel Announces Availability Of TAVLESSE® (Fostamatinib Disodium Hexahydrate) In Europe
By PR Newswire
Jul 9, 2020 8:19 AM EDT
PRESS RELEASES
Rigel To Present At The BMO 2020 Prescriptions For Success Healthcare Virtual Conference
By PR Newswire
Jun 17, 2020 7:30 AM EDT
PRESS RELEASES
Rigel To Present Four Posters Highlighting IRAK1/4 Inhibitor At The EULAR 2020 E-Congress
By PR Newswire
Jun 3, 2020 7:30 AM EDT
PRESS RELEASES
Rigel To Present At The Jefferies Virtual Healthcare Conference
By PR Newswire
May 26, 2020 7:30 AM EDT
PRESS RELEASES
Rigel Announces Change To Virtual Format For 2020 Annual Meeting Of Stockholders
By PR Newswire
May 1, 2020 7:30 AM EDT
PRESS RELEASES
Rigel Pharmaceuticals Provides Business Update
By PR Newswire
Jan 13, 2020 7:30 AM EST
PRESS RELEASES
Rigel To Present At The 38th Annual J.P. Morgan Healthcare Conference
By PR Newswire
Jan 9, 2020 2:30 AM EST
OPINION
Tuesday Investor Blog: Is the Bull Market in Stocks Being Ripped to Shreds?
By Brian Sozzi
Mar 20, 2018 4:43 PM EDT
STOCKS
15 Biotech Firms That Have Strong Potential to Be Acquired: Jefferies
By Kinsey Grant
Mar 20, 2018 2:58 PM EDT
STOCKS
Dimension Shares Rise On Sale to Ultragenyx - Biotech Movers
By Armie Margaret Lee
Oct 3, 2017 9:58 AM EDT
STOCKS
Rigel Jumps on Update on FDA Review of Bleeding Disorder Treatment
By Armie Margaret Lee
Oct 2, 2017 9:26 AM EDT
HEALTH
Otonomy Shares Rebound After Wednesday's Drop- Biotech Movers
By Armie Margaret Lee
Aug 31, 2017 9:39 AM EDT
